Skip to main content

Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis

Open
  • Protocol code: SRF201
  • EudraCT code: No aplica
  • Research group: Systemic Diseases
  • Service: Internal Medicine
  • Principal investigator:  Guillen Del Castillo, Alfredo
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Phase: Fase II